Cardiovascular Effects of Combining Subcutaneous or Intravenous Esketamine and the MAO Inhibitor Tranylcypromine for the Treatment of Depression: A Retrospective Cohort Study

BACKGROUND: (Es)ketamine and monoamine oxidase inhibitors (MAOIs), e.g., tranylcypromine, are therapeutic options for treatment-resistant major depression. Simultaneous administration is currently not recommended because of concern about hypertensive crises. OBJECTIVE: Our objective was to evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Ludwig, Vera M., Sauer, Cathrin, Young, Allan H., Rucker, James, Bauer, Michael, Findeis, Hannelore, Ritter, Philipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354966/
https://www.ncbi.nlm.nih.gov/pubmed/34283390
http://dx.doi.org/10.1007/s40263-021-00837-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354966/
https://www.ncbi.nlm.nih.gov/pubmed/34283390
http://dx.doi.org/10.1007/s40263-021-00837-6

Ejemplares similares